TECH - Bio-Techne
73.17
| Index: | S&P 500 | P/E: | 77.98 | EPS (ttm): | 0.94 | Insider Own: | 1.05% | Shs Outstand: | 158.88M | Perf Week: | -3.33% |
| Market Cap: | 11.92B | Forward P/E: | 33.52 | EPS next Y: | 2.18 | Insider Trans: | -0.93% | Shs Float: | 157.23M | Perf Month: | 6.48% |
| Income(ttm): | 150.69M | PEG: | 7.00 | EPS next Q: | 0.39 | Inst Own: | 98.74% | Short Float: | 2.59% | Perf Quarter: | -5.23% |
| Revenue(ttm): | 1.17B | P/S: | 10.17 | EPS this Y: | 6.08% | Inst Trans: | -0.84% | Short Ratio: | 4.51 | Perf Half Y: | -1.77% |
| Book/sh: | 13.46 | P/B: | 5.44 | EPS next Y: | 16.26% | ROA: | 5.49% | Short Interest: | 4.08M | Perf Year: | -3.55% |
| Cash/sh: | 1.15 | P/C: | 63.54 | EPS next 5Y: | 11.13% | ROE: | 7.29% | 52W Range: | 61.16 - 85.57 | Perf YTD: | -5.17% |
| Dividend Est.: | 0.26 (0.35%) | P/FCF: | 48.63 | EPS past 5Y: | 11.13% | ROI: | 5.97% | 52W High: | -14.49% | Beta: | 1.27 |
| Dividend TTM: | 0.32 (0.44%) | Quick Ratio: | 3.26 | Sales past 5Y: | 10.61% | Gross Margin: | 66.22% | 52W Low: | 19.64% | ATR (14): | 2.54 |
| Dividend Ex-Date: | Nov 08, 2024 | Current Ratio: | 4.56 | EPS Y/Y TTM: | -39.02% | Oper. Margin: | 20.88% | RSI (14): | 46.90 | Volatility: | 4.10% 3.26% |
| Employees: | 3100 | Debt/Eq: | 0.19 | Sales Y/Y TTM: | 2.41% | Profit Margin: | 12.86% | Recom: | 1.65 | Target Price: | 85.42 |
| Option/Short: | Yes / Yes | LT Debt/Eq: | 0.18 | EPS Q/Q: | -33.77% | Payout: | 30.61% | Rel Volume: | 2.43 | Prev Close: | 71.39 |
| Sales Surprise: | 3.30% | EPS Surprise: | 10.06% | Sales Q/Q: | 4.52% | Earnings: | Oct 30 BMO | Avg Volume: | 903.51K | Price: | 73.17 |
| SMA20: | -2.29% | SMA50: | -0.16% | SMA200: | -1.04% | Undervalued: 16.74% | Volume: | 2,194,125 | Change: | 2.49% | |
Graham Classic formula value: 25.96
(P/E=8 * 1g) Min value: 16.15
(current P/E * 2g) Max value: 84.61
Average value: 42.24
Bio-Techne Corp. is a global life sciences company providing innovative tools and bioactive reagents for the research and clinical diagnostic communities. Bio-Techne products assist scientific investigations into biological processes and the nature and progress of specific diseases. It operates through the Protein Sciences, and Diagnostics and Genomics segments. The Protein Sciences segment develops and manufactures purified proteins, and reagent solutions. The Diagnostics and Genomics segment develops and manufactures diagnostic products. The company was founded in 1976 and is headquartered in Minneapolis, MN.
Attention! Trading on the stock market involves financial risks and is not suitable for everyone. The www.stocks-expert.com does not provide financial market trading services; it is for informational purposes only and is not responsible for the consequences of your trading decisions or the operation of the software. Before starting to trade in any markets, make sure you understand the risks associated with trading and that you have a sufficient level of training.